Skip to main content

Does Rituxan cause hair loss?

Medically reviewed by Kristianne Hannemann, PharmD. Last updated on March 25, 2025.

Official answer

by Drugs.com

Hair loss is a possible side effect of Rituxan (rituximab), though it is not common. If hair loss occurs, it may affect the scalp, eyebrows, eyelashes, or body hair. Some people experience patchy hair loss or thinning, but in most cases, hair grows back after completing treatment.

How Common Is Hair Loss With Rituxan?

Hair loss (alopecia) does not seem to be a common side effect of Rituxan. Hair loss was rarely reported as a side effect in a systematic review and meta-analysis of Rituxan studies.

In a small clinical study of patients taking Rituxan for pemphigus vulgaris, 13% of patients taking Rituxan together with prednisone reported hair loss as a side effect. This was compared to 0% of patients taking prednisone alone. Hair loss was not commonly reported in studies of patients taking Rituxan for other health conditions.

FDA Reports

As of March 2024, the FDA Adverse Events Reporting System recorded 1,656 reports of hair loss in Rituxan users. However, these reports do not always confirm Rituxan as the cause, as patients may be taking other medications or have unrelated conditions.

What Should I Do If I Experience Hair Loss on Rituxan?

If you notice hair thinning or loss while taking Rituxan, speak with your healthcare provider. They can help determine the cause and suggest management strategies.

References

Belum, V. R., et. al. (2015). Alopecia in patients treated with molecularly targeted anticancer therapies. In: Annals of Oncology. DOI: https://doi.org/10.1093%2Fannonc%2Fmdv390

Cancer Research UK. (Updated Oct 2022). Rituximab. Accessed 07/13/2024 at https://www.cancerresearchuk.org/about-cancer/treatment/drugs/rituximab

FDA Adverse Events Reporting System (FAERS). US Food and Drug Administration (FDA). Accessed 07/13/2024 at https://fis.fda.gov/sense/app/95239e26-e0be-42d9-a960-9a5f7f1c25ee/sheet/45beeb74-30ab-46be-8267-5756582633b4/state/analysis

Mohebbi, N., et. al. (2022). Adverse drug reactions of Rituximab in patients suffering from autoimmune neurological diseases. In: DARU Journal of Pharamceutical Sciences. DOI: https://doi.org/10.1007%2Fs40199-022-00452-w

Puiu, T., et. al. (2022). Rituximab-Induced Alopecia Universalis in a Patient With Bullous Pemphigoid. In: Journal of Drugs in Dermatology. DOI: https://doi.org/10.36849/jdd.6690

Rituxan [package insert]. (Updated 2023). Genentech, Inc. Accessed 07/13/2024 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b172773b-3905-4a1c-ad95-bab4b6126563

Zhong, H., et. al. (2023). Clinical efficacy and safety of rituximab with membranous nephropathy: a meta-analysis. In: Archives of Medical Science. DOI: https://doi.org/10.5114%2Faoms.2020.99899

Read next

How will I feel after a Rituxan infusion?

After a Rituxan (rituximab) infusion you may experience certain side effects or adverse reactions that make you feel unwell. Common side effects include nausea, infusion-related reactions, and feeling tired. Continue reading

What are monoclonal antibodies?

Monoclonal antibodies (mAbs) are man-made proteins that mimic the natural antibodies produced by our immune systems. Monoclonal antibodies can be formulated into medicines to treat various types of illnesses, such as cancer, rheumatoid arthritis or psoriasis. Continue reading

How long does it take for Rituxan to work?

Patients treated with Rituxan may notice an early response within 7-8 weeks of treatment. Most rheumatoid arthritis patients will notice some improvement in their symptoms, such as improvement in their levels of pain and inflammation, within 16 weeks of starting treatment with Rituxan. Continue reading

Related medical questions

Drug information

Related support groups